Autism is classified as one of the
pervasive developmental disorders of the brain. It is not a disease.
People with
classical autism show three types of symptoms: impaired social
interaction, problems with verbal and nonverbal
communication, and unusual or severely limited activities and interests.
These symptoms can vary in severity. In
addition, people with autism often have abnormal responses to sounds,
touch, or other sensory stimulation.
Symptoms usually appear during the first three years of childhood and
continue through life. Researchers have
identified a number of genes that play a role in the disorder. In some
children, environmental factors also may play a
role. Studies of people with autism have found abnormalities in several
regions of the brain which suggest that
autism results from a disruption of early fetal brain development. Autism
affects an estimated 10 to 20 of every
10,000 people, depending on diagnostic criteria used, and strikes males
about four times more often than females.
Is there any treatment?
There is currently no cure for autism, but
appropriate treatment may foster relatively normal development and
reduce undesirable behaviors. Educational/behavioral therapies and drug
interventions are designed to remedy
specific symptoms. Educational/behavioral therapies emphasize highly
structured and often intensive skill-oriented
training. Doctors also may prescribe a variety of drugs to reduce symptoms
of autism Other interventions are
available, but few, if any, scientific studies support their use.
What is the prognosis?
People with autism have normal life
expectancies. Symptoms in many children improve with intervention or as
the
children age. Some people with autism eventually lead normal or
near-normal lives. Adolescence can worsen
behavior problems in some children, and parents should be ready to adjust
treatment for the child's changing needs.
About a third of children with autistic spectrum disorders eventually
develop epilepsy. The risk is highest in
children with severe cognitive impairment and motor deficits.
What research is being done?
NINDS supports studies aimed at identifying
the underlying brain abnormalities of autism through new methods of
brain imaging and other innovative techniques, and at identifying genes
that increase the risk of autism.
Researchers also are investigating possible biologic markers present at
birth that can identify infants at risk for
the development of autism. Other studies are examining how different brain
regions develop and function in relation
to each other, and how alterations in these relationships may result in
the signs and symptoms of autism.
Researchers hope these studies will provide new clues about how autism
develops and how brain abnormalities affect
behavior.
We
recommend about 8 mg of B6 per pound bodyweight (with some children needing significantly less or more),
and about 3-4 mg of magnesium per pound bodyweight (B6 must be
taken with magnesium). In the P5P form of B6, use 1-2 mg per pound
bodyweight Start
at a lower dose of B6, and increase gradually.
optimal
dosage unclear, but dosages of 12,000 mg have been used to
effectively treat depression and panic disorders, since it is
required for the
function of serotonin and other neurotransmitters.
150-250
IU.Fat-soluble,
so be cautious of overdosing
Diseases&Treatments
Disclaimer: This information is intended as a guide only. This information isoffered to you with the
understanding that it not be interpreted as medical or professional advice.
All
medical information needs to be carefully reviewed with your health care
provider.